Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)
PHASE1
To search for a Maximum Tolerated Dose (MTD) for the combination of daratum...
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
PHASE2
To determine if AEG35156 can enhance the combined complete remission (CR) a...
Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)
PHASE2
This is a prospective, open, non-randomized, non-controlled, phase II, clin...